|
|
Editorial |
| Eppur si muove (Galileo Galilei 1564-1642): the idiotypic dysregulation of autoantibodies as part of the etiology of SLE |
481 |
| Y Shoenfeld
|
|
Full Article (PDF)
|
|
Grand Rounds from International Lupus Centres – Edited by R Lahita |
| ‘Catastrophic’ antiphospholipid syndrome |
484 |
| PJ Maddison,
C Thorpe,
JRC Seale,
W Ahmed & GS Whiteley
|
|
Abstract
Full Article (PDF)
|
|
Papers |
| Induction of anti-DNA antibodies by immunization with anti-DNA antibodies: mechanism and characterization |
489 |
| F Satake,
N Watanabe,
N Miyasaka,
Y Kanai & T Kubota
|
|
Abstract
Full Article (PDF)
|
|
| Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement |
498 |
| E Trysberg,
H Carlsten & A Tarkowski
|
|
Abstract
Full Article (PDF)
|
|
| Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis |
504 |
| H Nossent,
J Berden & T Swaak
|
|
Abstract
Full Article (PDF)
|
|
| The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms |
511 |
| MPK Soo,
SK Chow,
CT Tan,
N Nadior,
SS Yeap & HB Hoh
|
|
Abstract
Full Article (PDF)
|
|
| Determination of autoantibodies to annexin XI in systemic autoimmune diseases |
515 |
| CS Jørgensen,
G Levantino,
G Houen,
S Jacobsen,
P Halberg,
S Ullman,
MA Khamashta,
K Asmussen,
P Oxholm,
MK Jørgensen,
WJ van Venrooij & A Wiik
|
|
Abstract
Full Article (PDF)
|
|
| Subarachnoid hemorrhage and systemic lupus erythematosus |
521 |
| A Mimori,
T Suzuki,
M Hashimoto,
H Nara,
T Yoshio,
J-I Masuyama,
H Okazaki,
D Hirata,
S Kano & S Minota
|
|
Abstract
Full Article (PDF)
|
|
| Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine |
527 |
| SE Walker,
KL Smarr,
JC Parker,
DN Weidensaul,
W Nelson & RW McMurray
|
|
Abstract
Full Article (PDF)
|
|
| Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus erythematosus |
534 |
| GM Devins,
SM Edworthy & the ARAMIS Lupus State Models Research Group
|
|
Abstract
Full Article (PDF)
|
|
Short Report |
| Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study |
542 |
| H Bateman,
Y Yazici,
L Leff,
M Peterson & SA Paget
|
|
Abstract
Full Article (PDF)
|
|
Case Reports |
| Anetoderma in systemic lupus erythematosus: relationship to antiphospholipid antibodies |
545 |
| C Montilla & D Alarcón-Segovia
|
|
Abstract
Full Article (PDF)
|
|
| Crossing of antinuclear antibodies and anti-leishmania antibodies |
548 |
| B Granel,
J Serratrice,
L Swiader,
F Gambarelli,
L Daniel,
C Fossat,
S Hesse-Bonérandi,
X Pache,
P Disdier & PJ Weiller
|
|
Abstract
Full Article (PDF)
|
|
| Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL) |
551 |
| T-NK Chou,
T-C Hsu,
R-M Chen,
L-I Lin & GJ Tsay
|
|
Abstract
Full Article (PDF)
|
|
| Lamotrigine-induced lupus |
555 |
| P Sarzi-Puttini,
B Panni,
M Cazzola,
S Muzzupappa & M Turiel
|
|
Abstract
Full Article (PDF)
|
|
Pulmonary embolism and transitory anti- 2-GPI antibodies in an adult with chicken pox |
558 |
| V Viseux,
L Darnige,
E Carmi,
G Chaby,
JF Poulain,
R Cevallos,
C Lok & JP Denoeux
|
|
Abstract
Full Article (PDF)
|
|
Letter to the Editor |
| Should low-dose aspirin also be a background therapy for all patients with systemic lupus erythematosus (SLE)? |
561 |
| AN Malaviya & M Mourou
|
|
Full Article (PDF)
|
|
Book Review |
| Cancer & Autoimmunity, by Y Shoenfeld and ME Gershwin |
563 |
| GRV Hughes
|
|
Full Article (PDF)
|
|
